ACETAMINOPHEN COMPLICATIONS BEFORE VS AFTER FDA MANDATE TO LIMIT ACETAMINOPHEN DOSE IN PRESCRIPTION COMBINATION OPIOID PRODUCTS

被引：0
|
作者：
Orandi, Babak [1 ]
McLeod, Chandler [1 ]
Lee, William M. [2 ]
Karvellas, Constantine J. [3 ,4 ,5 ]
McGuire, Brendan M. [6 ]
Lewis, Cora E. [7 ]
Terrault, Norah [8 ]
Locke, Jayme E. [1 ]
机构：
[1] Univ Alabama Birmingham, Surg, Birmingham, AL USA
[2] Univ Texas Southwestern Med Ctr Dallas, Div Digest & Liver Dis, Dallas, TX 75390 USA
[3] Univ Alberta, Dept Crit Care Med, Edmonton, AB, Canada
[4] Univ Alberta, Div Gastroenterol, Liver Unit, Edmonton, AB, Canada
[5] Univ Alberta, Edmonton, AB, Canada
[6] Univ Alabama Birmingham, Div Gastroenterol & Hepatol, Birmingham, AL USA
[7] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA
[8] Univ Southern Calif, Div Gastrointestinal & Liver Dis, Los Angeles, CA 90007 USA
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
4004
引用
收藏
页码：S1234 / S1234
页数：1
相关论文
共 34 条
  • [1] Evaluation of a Food and Drug Administration Mandate to Limit Acetaminophen in Prescription Combination Products
    Goldberger D.
    Vearrier D.
    Journal of Medical Toxicology, 2017, 13 (4) : 303 - 308
  • [2] FDA limits acetaminophen in prescription combination products
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (04) : 476 - 476
  • [3] Association of FDA Mandate Limiting Acetaminophen (Paracetamol) in Prescription Combination Opioid Products and Subsequent Hospitalizations and Acute Liver Failure
    Orandi, Babak J.
    McLeod, M. Chandler
    MacLennan, Paul A.
    Lee, William M.
    Fontana, Robert J.
    Karvellas, Constantine J.
    McGuire, Brendan M.
    Lewis, Cora E.
    Terrault, Norah M.
    Locke, Jayme E.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (09): : 735 - 744
  • [4] Comment on: Evaluation of a Food and Drug Administration Mandate to Limit Acetaminophen in Prescription Combination Products
    Mullins, Michael E.
    Dunn, S. Eliza
    JOURNAL OF MEDICAL TOXICOLOGY, 2018, 14 (01) : 112 - 113
  • [5] Evaluation of a US Food and Drug Administration mandate to limit acetaminophen in prescription combination products
    Goldberger, David
    Vearrier, David
    CLINICAL TOXICOLOGY, 2017, 55 (05) : 420 - 420
  • [6] Comment on: Evaluation of a Food and Drug Administration Mandate to Limit Acetaminophen in Prescription Combination Products
    Michael E. Mullins
    S. Eliza Dunn
    Journal of Medical Toxicology, 2018, 14 : 112 - 113
  • [7] Association of FDA Mandate Limiting Acetaminophen in Prescription Combination Opioid Products and Subsequent Hospitalizations, Acute Liver Failure, and Liver Transplant
    Orandi, B.
    McLeod, C.
    MacLennan, P.
    Lee, W.
    Fontana, R.
    Karvellas, C.
    McGuire, B.
    Lewis, C.
    Terrault, N.
    Locke, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S607 - S607
  • [8] FDA acts to limit exposure to acetaminophen in combination products
    McCarthy, Michael
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [9] FDA Asks Physicians to Stop Prescribing High-Dose Acetaminophen Products
    Mitka, Mike
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (06): : 563 - 563
  • [10] Mandating limits on acetaminophen in combination opioid products does not decrease incidence of hepatotoxicity
    Goldberger, David
    Vearrier, David
    CLINICAL TOXICOLOGY, 2016, 54 (08) : 768 - 768
1234